Pediatric Neurology

The Long-Term Path: Outlook and Daily Life

At a Glance

Outlook varies by diagnosis: PKD attacks often lessen or remit in young adulthood, while GLUT1 deficiency may require lifelong management and episodic ataxia or PNKD can persist. Sleep, meal planning, school support, and emotional care help children manage daily life.

As you look toward the future, it is natural to wonder how this condition will evolve as your child grows. While the unpredictability of “attacks” can be a source of significant stress, the long-term outlook for many children on this spectrum is often encouraging ^[1]^[2].

The Long-Term Outlook: Growing Through the Symptoms

For many families, the teenage years represent a turning point. The “natural history”—or typical course—of these disorders varies depending on the underlying cause and severity:

Paroxysmal Kinesigenic Dyskinesia (PKD): This often has a very favorable long-term prognosis. Attacks typically begin in childhood or early adolescence, but they frequently diminish in frequency and intensity as a person reaches their 20s and 30s ^[3]^[4]. Many patients eventually see their symptoms disappear (remit) entirely ^[5].
Glut1 Deficiency (SLC2A1): This is a lifelong condition that requires ongoing management, but it often “stabilizes” over time ^[6]. While some children may see their movement symptoms change or even become more prominent as they enter adulthood, long-term use of the ketogenic diet or other energy-supportive therapies can provide significant, lasting relief from attacks ^[7]^[8]. However, it may include lasting developmental, cognitive, speech, or mobility-related disability despite treatment.
Episodic Ataxia and PNKD: These are more variable. While attacks may improve with age for some, others may experience persistent balance issues or require continued medication to keep symptoms at bay ^[2]^[9].

Daily Management and School Success

Navigating school requires a proactive partnership between your family and the school staff. Because these conditions are rare, you will likely need to be your child’s primary advocate to ensure they have the right accommodations, often through a 504 Plan or an Individualized Education Program (IEP) in the U.S., or equivalent accommodations elsewhere ^[10]. The school plan should describe the child’s observed typical event, the agreed response, and when to call emergency services.

Dietary Compliance: If your child is on a medical diet (like the ketogenic diet), the school must have a clear, written plan for meals and snacks. This includes a list of “safe” foods, strict instructions that they are not to share food with other students, and what to do for missed meals or illness ^[11]^[12].
Preventing “Energy Dips”: For children with energy-related movement disorders, having a clinician- and dietitian-approved written plan for scheduled snacks throughout the day is vital to prevent triggers like fasting or hunger, ensuring it aligns perfectly with any prescribed ketogenic ratios ^[13]^[11].
Physical Activity: Your child should be encouraged to participate in PE and sports, but they may need “activity breaks” or the ability to stop immediately if they feel an attack starting ^[14]^[15].
Sleep Hygiene: Fatigue is a universal trigger. Maintaining a strict sleep schedule, even on weekends, is one of the most effective non-medical ways to reduce attack frequency ^[16]^[17].

Addressing the Emotional Impact

Living with an unpredictable condition can take a psychological toll. Children may experience anticipatory anxiety (fear of future attacks) or a deep-seated fear of having a visible episode in front of their peers ^[18]^[19].

Validate the Stress: It is normal for children to feel “on edge” or embarrassed. In one specific study of patients with PKD, nearly 41% reported symptoms of depression and 26% reported anxiety, highlighting the need for routine mental health screening and clear guidance to seek urgent help for severe functional decline ^[18]. Early support from a pediatric psychologist can provide your child with “coping toolkits” to manage these feelings ^[20].
Education as Empowerment: Helping your child understand their own “body signals” and triggers can help them feel more in control. When they can say, “I need to sit down because I’m feeling shaky,” they move from being a passenger to a participant in their own care ^[10].
Family Planning: As your child approaches adulthood, genetic counseling becomes an important resource. This allows them to understand the risks of passing the gene to their own children and to explore options for their future ^[21].

Common questions in this guide

Will my child’s attacks improve with age?

It depends on the underlying diagnosis. Paroxysmal kinesigenic dyskinesia attacks often become less frequent and less intense in the 20s and 30s and may eventually stop; Glut1 deficiency usually requires lifelong management, while episodic ataxia and PNKD can improve or persist.

What should a school plan include for a child with these movement disorders?

A 504 Plan, IEP, or equivalent written plan can explain the child’s typical event, how staff should respond, and when to call emergency services. If diet therapy is prescribed, it should also list approved foods, scheduled snacks, missed-meal or illness instructions, and activity modifications.

How can we help prevent attacks during the school day?

Follow clinician- and dietitian-approved meal and snack timing, especially if the child uses a ketogenic diet, and avoid fasting or hunger. Regular sleep and permission to take activity breaks may also reduce triggers.

Are these attacks seizures, and will my child remain conscious?

Some movement attacks in this group are not seizures, and the child may remain conscious, but episodes can differ by diagnosis. Ask the treating clinician to document what your child’s typical event looks like and exactly when emergency help is needed.

How can I tell if my child is struggling emotionally?

Watch for increasing fear of public episodes, embarrassment, avoidance of school or activities, low mood, or loss of daily functioning. Validate your child’s feelings, ask the care team about routine anxiety and depression screening, and seek prompt help for severe functional decline.

When should my child begin genetic counseling?

As your child approaches adulthood, genetic counseling can explain inheritance and discuss how the condition could affect future children. The right timing depends on the child’s diagnosis and readiness, so ask the care team when to begin.

Get notified when new evidence is published on Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (21)

1
[Paroxysmal dyskinesias in pediatrics: diagnostic route and treatment].
Baltar Yanes F, Garcia MJ, Deutsch H
Medicina 2026; (86 Suppl 3()):28-36.
PMID: 42659547
2
Paroxysmal movement disorders - practical update on diagnosis and management.
De Gusmao CM, Silveira-Moriyama L
Expert review of neurotherapeutics 2019; (19(9)):807-822 doi:10.1080/14737175.2019.1648211.
PMID: 31353980
3
Clinical characteristics and PRRT2 gene mutation analysis of sporadic patients with paroxysmal kinesigenic dyskinesia in China.
Zhang Y, Li L, Chen W, et al.
Clinical neurology and neurosurgery 2017; (159()):25-28 doi:10.1016/j.clineuro.2017.05.004.
PMID: 28525812
4
Clinical features and genetic analysis of paroxysmal kinesigenic dyskinesia in children.
Zheng LP, Ye YP, Wang SP, et al.
Frontiers in neurology 2026; (17()):1788601 doi:10.3389/fneur.2026.1788601.
PMID: 42037713
5
Multilevel Structure-Function Coupling Reveals Network Signatures of Remission in Paroxysmal Kinesigenic Dyskinesia.
Li Y, Fang K, Li Z, et al.
Movement disorders : official journal of the Movement Disorder Society 2026; doi:10.1002/mds.70512.
PMID: 42779529
6
One Molecule for Mental Nourishment and More: Glucose Transporter Type 1-Biology and Deficiency Syndrome.
Vulturar R, Chiș A, Pintilie S, et al.
Biomedicines 2022; (10(6)) doi:10.3390/biomedicines10061249.
PMID: 35740271
7
Glucose transporter type 1 deficiency syndrome and the ketogenic diet.
Schwantje M, Verhagen LM, van Hasselt PM, Fuchs SA
Journal of inherited metabolic disease 2020; (43(2)):216-222 doi:10.1002/jimd.12175.
PMID: 31605543
8
From splitting GLUT1 deficiency syndromes to overlapping phenotypes.
Hully M, Vuillaumier-Barrot S, Le Bizec C, et al.
European journal of medical genetics 2015; (58(9)):443-54.
PMID: 26193382
9
Paroxysmal movement disorders.
Magrinelli F, Bhatia KP
Handbook of clinical neurology 2024; (203()):145-156 doi:10.1016/B978-0-323-90820-7.00010-0.
PMID: 39174246
10
Children's experiences of congenital heart disease: a systematic review of qualitative studies.
Chong LSH, Fitzgerald DA, Craig JC, et al.
European journal of pediatrics 2018; (177(3)):319-336 doi:10.1007/s00431-017-3081-y.
PMID: 29327140
11
Diagnosis and treatment recommendations for glucose transporter 1 deficiency syndrome.
Zhang MJ, Wu , Yu LF, et al.
World journal of pediatrics : WJP 2025; (21(2)):149-158 doi:10.1007/s12519-024-00864-5.
PMID: 39745620
12
Evaluation of E-Health Applications for Paediatric Patients with Refractory Epilepsy and Maintained on Ketogenic Diet.
Costa AM, Marchiò M, Bruni G, et al.
Nutrients 2021; (13(4)) doi:10.3390/nu13041240.
PMID: 33918854
13
Complications During Ketogenic Diet Initiation: Prevalence, Treatment, and Influence on Seizure Outcomes.
Lin A, Turner Z, Doerrer SC, et al.
Pediatric neurology 2017; (68()):35-39 doi:10.1016/j.pediatrneurol.2017.01.007.
PMID: 28188074
14
Prolonged Episodes of Paroxysmal Exertion-Induced Dystonia in Glut1 Deficiency Syndrome.
Klepper J, Kiesel L, Runkel E
Neuropediatrics 2026; (57(4)):286-288 doi:10.1055/a-2883-4228.
PMID: 42314693
15
Clinical, practical, and psychosocial challenges of living with glucose transporter type 1 deficiency syndrome.
El Zibaoui R, McDonald TJW, Steele G, et al.
Seizure 2026; (137()):105-111 doi:10.1016/j.seizure.2026.03.005.
PMID: 41830650
16
Protein mutated in paroxysmal dyskinesia interacts with the active zone protein RIM and suppresses synaptic vesicle exocytosis.
Shen Y, Ge WP, Li Y, et al.
Proceedings of the National Academy of Sciences of the United States of America 2015; (112(10)):2935-41 doi:10.1073/pnas.1501364112.
PMID: 25730884
17
Genetic testing for non-parkinsonian movement disorders: Navigating the diagnostic maze.
Shambetova C, Klein C
Parkinsonism & related disorders 2024; (121()):106033 doi:10.1016/j.parkreldis.2024.106033.
PMID: 38429185
18
Depression, anxiety, and quality of life in paroxysmal kinesigenic dyskinesia patients.
Tian WT, Huang XJ, Liu XL, et al.
Chinese medical journal 2017; (130(17)):2088-2094 doi:10.4103/0366-6999.213431.
PMID: 28836553
19
Psychiatric and Psychological Impact of Chronic Skin Disease.
Jafferany M, Pastolero P
The primary care companion for CNS disorders 2018; (20(2)).
PMID: 29701929
20
Identifying key components for a psychological intervention for people with vitiligo - a quantitative and qualitative study in the United Kingdom using web-based questionnaires of people with vitiligo and healthcare professionals.
Ahmed A, Steed L, Burden-Teh E, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2018; (32(12)):2275-2283 doi:10.1111/jdv.15168.
PMID: 29972710
21
Glucose Transporter Deficiency Syndrome Type 1 (Glut1-DS): New Insights From a Brazilian Cohort of Patients.
Sobrinho LMF, Fontana JC, Lorea CF, et al.
JIMD reports 2026; (67(5)):e70113 doi:10.1002/jmd2.70113.
PMID: 42638834

This page is for informational purposes only and does not constitute medical advice about your child’s prognosis, school plan, diet, or mental health; discuss individual decisions with your child’s care team.